Pharma: Other News To Note
Forest Laboratories Inc., of New York, said it entered a settlement agreement with Mumbai, India-based Glenmark Pharmaceuticals Ltd., and its affiliates, related to patent infringement litigation brought by Forest in response to Glenmark's abbreviated new drug application (ANDA) seeking to market generic versions of Forest's Bystolic (nebivolol) tablets.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter